Vitamin D and gastrointestinal diseases: Inflammatory bowel disease and colorectal cancer

Therapeutic Advances in Gastroenterology

Volumn 4, Issue 1, 2011, Pages 49-62

  Raman, Maitreyi ^a   Milestone, Andrew N ^a   Walters, Julian R F ^b   Har, Ailsa L ^c   Ghosh, Subrata ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b ST MARK S HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colorectal cancer; Immunology; Inflammatory bowel disease; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; COLECALCIFEROL; CYCLOSPORIN; DOCOSAHEXAENOIC ACID; FISH OIL; GLUCOCORTICOID; ICOSAPENTAENOIC ACID; INFLIXIMAB; RAPAMYCIN; STEROID; VITAMIN D; VITAMIN D RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; COLORECTAL CANCER; DIET SUPPLEMENTATION; ENTERITIS; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGY; GASTROINTESTINAL DISEASE; HUMAN; HYPERCALCEMIA; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLIC BONE DISEASE; MULTIPLE SCLEROSIS; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TUBERCULOSIS; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

EID: 80051723666     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X10377820     Document Type: Review

References (95)

1. Aloia, J.F., Patel, M., DiMaano, R., Li-Ng, M., Talwar, S.A., Mikhail, M. et al. (2008) Vitamin D intake to attain a serried serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 87: 1952-1958. (Pubitemid 351872664)
2. Alroy, I., Towers, T.L. and Freedman, L.P. (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15: 5789-5799.
3. Jelkovic, Z., Vojinovic, J., Pejnovic, N., Popovic, M., Dujic, A., Mitrovic, D. et al. (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17: 453-456. (Pubitemid 29343630)
4. Andreassen, H., Rix, M., Brot, C. and Eskildsen, P. (1998) Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 33: 1087-1093. (Pubitemid 28505654)
5. Andreassen, H., Rungby, J., Dahlerup, J.F. and Mosekilde, L. (1997) Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 32: 1247-1255. (Pubitemid 28023130)
6. Banchereau, F., Briere, C., Caux, J., Davoust, S., Lebecque, Y.J. and Liu, B. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
7. Barger-Lux, M.J., Heaney, R.P., Lanspa, S.J., Healy, J.C. and DeLuca, H.F. (1996) An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80: 406-411.
8. Barrat, F.J., Cua, D.J., Boonstra, A., Richards, D.F., Crain, C., Savelkoul, H.F. et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4(p) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. Combination of calcitriol and dexamethasone induced high nos of IL10 producing T cells. J Exp Med 195: 603-616. (Pubitemid 34461505)
9. Berer, A., Stockl, J., Majdic, O., Wagner, T., Kollars, M., Lechner, K. et al. (2000) 1,25- Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28: 575-583. (Pubitemid 30254459)
10. Bhalla, A.K., Amento, E.P., Clemens, T.L., Holick, M.F. and Krane, S.M. (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57: 1308-1310. (Pubitemid 14209439)
11. Bhalla, A.K., Amento, E.P., Serog, B. and Glimcher, L.H. (1984) 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133: 1748-1754. (Pubitemid 14035260)
12. Brennan, A., Katz, D.R., Nunn, J.D., Barker, S., Hewison, M., Fraher, L.J. et al. (1987) Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61: 457-461. (Pubitemid 17127352)
13. Canning, M.O., Grotenhuis, K., deWit, H., Ruwhof, C. and Drexhage, H.A. (2001) 1-alpha, 25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145: 351-357. (Pubitemid 32825669)
14. Cantorna, M.T., Munsick, C., Bemiss, C. and Mahon, B.D. (2000) 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine IBD. J Nutr 130: 2648-2652.
15. Carlberg, C. (2003) Current understanding of the function on the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164: 29-42.
16. Carlberg, C. and Polly, P. (1998) Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Expr 8: 19-42.
17. Carr, I. and Mayberry, J.F. (1999) The effects of migration on ulcerative colitis: A three-year prospective study among Europeans and first and secondgeneration South Asians in Leicester (1991-1994). Am J Gastroenterol 94: 2918-2922. (Pubitemid 29482758)
18. Cippitelli, M. and Santoni, A. (1998) Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur J Immunol 28: 3017-3030. (Pubitemid 28470247)
19. Daniel, C., Sartory, N.A., Zahn, N., Radeke, H.H. and Stein, J.M. (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324: 23-33. (Pubitemid 350294165)
20. Davie, M.W., Lawson, D.E., Emberson, C., Barnes, J.L., Roberts, G.E. and Barnes, N.D. (1982) Vitamin D from skin: Contribution to vitamin D status compared with oral vitamin D in normal and anticonvulsant- treated subjects. Clin Sci 63: 461-472. (Pubitemid 12006344)
21. De Ley, M., de Vos, R., Hommes, D.W. and Stokkers, P.C. (2007) Fish oil for induction of remission in ulcerative colitis. Cochrane Database Syst Rev Issue 4. Art. No.: CD005986.
22. Diaz, G.D., Paraskeva, C., Thomas, M.G., Binderup, L. and Hague, A. (2000) Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res 60: 2304-2312. (Pubitemid 30225198)
23. Driscoll Jr, R.H., Meredith, S.C., Sitrin, M. and Rosenberg, I.H. (1982) Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 83: 1252-1258. (Pubitemid 13235925)
24. Feskanich, D., Ma, J., Fuchs, C.S., Kirkner, G.J., Hankinson, S.E., Hollis, B.W. et al. (2004) Plasma vitamin D metbolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13: 1502-1508. (Pubitemid 39202318)
25. Freedman, D.M., Looker, A.C., Chang, S.C. and Graubard, B.I. (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99: 1594-1602.
26. Food Standards Agency (2003) Safe Upper Levels for Vitamins and Minerals, Foods Standards Agency: London.
27. Froicu, M., Weaver, V., Wynn, T.A., McDowell, M.A., Welsh, J.E. and Cantorna, M.T. (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 2386-2392. (Pubitemid 37542204)
28. Froicu, M. and Cantorna, M.T. (2007) Vitamin D and the VDR are critical for control of the innate immune response to colonic injury. BMC Immunol 8: 5.
29. Gibson, P.R. (2004) Increased gut permeability in Crohn's disease: Is TNF the link? Gut 53: 1724-1725. (Pubitemid 39556884)
30. Goldberg, P., Fleming, M.C. and Picard, E.H. (1986) Multiple sclerosis: Decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21: 193-200. (Pubitemid 17201931)
31. Gorham, E.D., Garland, C.F., Garland, F.C. et al. (2007) Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 32: 210-216. (Pubitemid 46223622)
32. Gorham, E.D., Garland, C.F., Garland, F.C., Grant, W.B., Mohr, S.B., Lipkin, M. et al. (2005) Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97: 179-194. (Pubitemid 41546228)
33. Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A.M. and Adorini, L. (2001) Regulatory T cells induced by 1a,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167: 1945-1953. (Pubitemid 32747499)
34. Griffin, M.D., Lutz, W., Phan, V.A., Bachman, L.A., McKean, D.J. and Kumar, R. (2000) Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270: 701-708. (Pubitemid 30444768)
35. Griffin, M.D., Lutz, W., Phan, V.A., Bachman, L.A., McKean, D.J. and Kumar, R. (2001) Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 22: 22.
36. Harries, A.D., Brown, R., Heatley, R.V., Williams, L.A., Woodhead, S. and Rhodes, J. (1985) Vitamin D status in Crohn's disease: Association with nutrition and disease activity. Gut 26: 1197-1203. (Pubitemid 16216265)
37. Heaney, R.P., Davies, K.M., Chen, T.C., Holick, M.F. and Barger-Lux, M.J. (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204-210. (Pubitemid 36015393)
38. Holick, M.F. (2004) Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371. (Pubitemid 41115577)
39. Holick, M.F. (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
40. Hollis, B.W. and Wagner, C.L. (2004) Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 79: 717-726. (Pubitemid 41103872)
41. Jenab, M., Bueno-de-Mesquita, H.B., Ferrari, P., van Duijnhoven, F.J., Norat, T., Pischon, T. et al. (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: A nested case-control study. BMJ 340: b5500.
42. Jirapongsananuruk, O., Melamed, I. and Leung, D.Y. (2000) Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1 but not TH2 responses. J Allergy Clin Immunol 106: 981-985.
43. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A.H. (2000) Induction of interleukin 10-producing, nonproliferating CD4(p) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192: 1213-1222.
44. Joseph, A.J., George, B., Pulimood, A.B., Seshadri, M.S. and Chacko, A. (2009) 25(OH) Vitamin D level in Crohn's disease association with sun exposure and disease activity. Indian J Med Res 130: 133-137.
45. Kimball, S.M., Ursell, M.R., O'Connor, P. and Vieth, R. (2007) Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 86: 645-651. (Pubitemid 47435831)
46. Kong, J., Zhang, Z., Musch, M.W., Ning, G., Sun, J., Hart, J. et al. (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294: G208-G216.
47. Kühn, R., Löhler, J., Rennick, D., Rajewsky, K. and Müller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
48. Kunkel, E.J. and Butcher, E.C. (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1-4. (Pubitemid 34143211)
49. Lappe, J.M., Travers-Gustafson, D., Davies, K.M., Recker, R.R. and Heaney, R.P. (2007) Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 85: 1586-1591. (Pubitemid 46890428)
50. Lemire, J.M., Archer, D.C., Beck, L. and Spiegelberg, H.L. (1995) Immunosuppressive actions of 1,25- dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 125: 1704S-1708S.
51. Li, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q. and Cao, L.P. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238. (Pubitemid 34787360)
52. Lips, P. (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90: 611-614. (Pubitemid 38844358)
53. Liu, P.T., Stenger, S., Li, H., Wenzel, L., Tan, B.H., Krutzik, S.R. et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
54. Loftus Jr, E.V. and Sandborn, W.J. (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31: 1-20. (Pubitemid 34733030)
55. Mahon, B.D., Gordon, S.A., Cruz, J., Cosman, F. and Cantorna, M.T. (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134: 128-132. (Pubitemid 36050838)
56. Mannon, P.J., Fuss, I.J., Mayer, L., Elson, C.O., Sandborn, W.J., Present, D. et al. (2004) Anti-interleukin- 12 antibody for active Crohn's disease. N Eng J Med 351: 2069-2079. (Pubitemid 39482500)
57. Manolagas, S.C., Provvedini, D.M., Murray, E.J., Tsoukas, C.D. and Deftos, L.J. (1986) The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J Clin Endocrinol Metab 63: 394-400. (Pubitemid 16035687)
58. Marth, T., Zeitz, M., Ludviksson, B.R., Strober, W. and Kelsall, B.L. (1999) Extinction of IL-12 signalling promotes FAS-mediated apotosis of antigen-specific T-cells. J Immunol 162: 7233-7240. (Pubitemid 29277695)
59. Martineau, A.R., Wilkinson, R.J., Wilkinson, K.A., Newton, S.M., Kampmann, B., Hall, B.M. et al. (2007) A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176: 208-213. (Pubitemid 47057859)
60. Meggouh, F., Lointier, P. and Saez, S. (1991) Sex steroid and 1,25 dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res 51: 1227-1233.
61. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. and O'Garra, A. (2001) Interleukin- 10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
62. Moum, B., Aadland, E., Ekbom, A. and Vatn, M.H. (1996) Seasonal variations in the onset of ulcerative colitis. Gut 38: 376-378. (Pubitemid 26074317)
63. Nagpal, S., Na, S. and Rathnachalam, R. (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687 [Epub 2005 Mar 29; Review]. (Pubitemid 41127276)
64. Nordvik, I., Myhr, K.M., Nyland, H. and Bjerve, K.S. (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102: 143-149. (Pubitemid 30645133)
65. Peeters, M., Geypens, B., Claus, D., Nevens, H., Ghoos, Y., Verbeke, G. et al. (1997) Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 113: 802-807. (Pubitemid 27381139)
66. Penna, G. and Adorini, L. (2000) 1 Alpha, 25- Dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T-cell activation. J Immunol 164: 2405-2411. (Pubitemid 30115468)
67. Piemonti, P., Monti, M., Sironi, P., Fraticelli, B.E., Leone, E., Dal Cin, P. et al. (2000) Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164: 4443-4451.
68. Probert, C.S., Jayanthi, V., Pinder, D., Wicks, A.C. and Mayberry, J.F. (1992) Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33: 687-693.
69. Probert, C.S., Mayberry, J.F. and Mann, R. (1990) Inflammatory bowel disease in the rural Indian subcontinent: A survey of patients attending mission hospitals. Digestion 47: 42-46.
70. Provvedini, D.M., Tsoukas, C.D., Deftos, L.J. and Manolagas, S.C. (1983) 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181-1183.
71. Rigby, W.F., Stacey, T. and Fanger, M.W. (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74: 1451-1455. (Pubitemid 15200239)
72. Sellu, D.P. (1986) Seasonal variation in onset of exacerbations of ulcerative proctocolitis. J R Coll Surg Edinb 31: 158-160. (Pubitemid 16009871)
73. Sigmundsdottir, H., Pan, J., Debes, G.F., Alt, C., Habtezion, A., Soler, D. et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8: 285-293. (Pubitemid 46745378)
74. Stamp, T.C. (1975) Factors in human vitamin D nutrition and in the production and cure of classical rickets. Proc Nutr Soc 34: 119-130.
75. Stio, M., Martinesi, M., Bruni, S., Treves, C., Mathieu, C., Verstuyf, A. et al. (2007) The vitamin D analogue TX 527 blocks NF-B activation in peripheral blood mononuclear cells of patients with Crohn's disease. J Steroid Biochem Mol Biol 103: 51-60. (Pubitemid 44821819)
76. Stio, M., Treves, C., Celli, A., Tarantino, O., d'Albasio, G. and Bonanomi, A.G. (2002) Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T lymphocyte proliferation in active ulcerative colitis. Am J Gastroenterol 97: 679-689. (Pubitemid 34245898)
77. Stio, M., Treves, C., Martinesi, M. and Bonanomi, A.G. (2005) Biochemical effects of KH 1060 and anti- TNF monoclonal antibody on human peripheral blood mononuclear cells. Int Immunopharmacol 5: 649-659. (Pubitemid 40248320)
78. van Etten, E. (2007) Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta. J Steroid Biochem Mol Biol 103: 546-551.
79. van Halteren, A.G., van Etten, E., de Jong, E.C., Bouillon, R., Roep, B.O. and Mathieu, C. (2002) Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25-dihydroxyvitamin D(3). Diabetes 51: 2119-2125. (Pubitemid 34729016)
80. Vandewalle, B., Adenis, A., Hornez, L., Revillion, F. and Lefebvre, J. (1994) 1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett 86: 67-73.
81. Veldman, C.M., Cantorna, M.T. and DeLuca, H.F. (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374: 334-338. (Pubitemid 30120270)
82. Vieth, R. (1999) Vitamin D supplementation, 25-hydroxyvitamin D levels and safety. Am J Clin Nutr 69: 842-856. (Pubitemid 29205056)
83. Vieth, R. (2004) Why the optimal requirement for Vitamin D(3) is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90: 575-579. (Pubitemid 38844352)
84. Vieth, R. (2006) Critique of the considerations for establishing the tolerable upper intake level for vitamin D: Critical need for revision upwards. J Nutr 136: 1117-1122.
85. Vieth, R., Chan, P.R. and MacFarlane, G.D. (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73: 288-294. (Pubitemid 32109858)
86. Vogelsang, H., Ferenci, P., Woloszczuk, W., Resch, H., Herold, C., Frotz, S. et al. (1989) Bone disease in vitamin D deficient patients with Crohn's disease. Dig Dis Sci 34: 1094-1099. (Pubitemid 19188893)
87. Wactawski-Wende, J., Kotchen, J.M., Anderson, G.L., Assaf, A.R., Brunner, R.L., O'Sullivan, M.J. et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354: 684-696. (Pubitemid 43247139)
88. Wang, T.T., Dabbas, B., Laperriere, D., Bitton, A.J., Soualhine, H., Tavera-Mendoza, L.E. et al. (2010) Direct and indirect induction by 1,25 dihydroxyvitamin D3 of the NOD2/CARD15-defnsin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 285: 2227-2231.
89. Warrell, D.A. (1996) Oxford Textbook of Medicine, 3rd edition edn, Oxford University Press: Oxford, pp. 3992-3998.
90. Wu, K., Feskanich, D., Fuchs, C.S., Willett, W.C., Hollis, B.W. and Giovannucci, E.L. (2007) A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99: 1120-1129. (Pubitemid 47241396)
91. Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V. and Brenner, H. (2009) Meta-analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk. Alim Pharmacol Ther 30: 113-125.
92. Zeng, L. and Anderson, F.H. (1996) Seasonal change in the exacerbations of Crohn's disease. Scand J Gastroenterol 31: 79-82. (Pubitemid 26018609)
93. Zhu, Y., Mahon, B.D., Froicu, M. and Cantorna, M.T. (2005) Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35: 217-224. (Pubitemid 40123868)
94. Zittermann, A. (2006) Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92: 39-48. (Pubitemid 43831966)
95. Zittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Körfre, R. and Stehle, P. (2003) Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41: 105-112. (Pubitemid 36044411)